Make your money go further for just 25p per day

Fascinating business but is the valuation really justified?

01/04/2015 · Bioventix PLC (BVXP) 

Bioventix is a business engaged in the creation and engineering of antibodies. It was incorporated in 2003, and began trading on PLUS Market in 2010, before moving to AIM in April 2014. It has developed technology to produce cell lines that secrete sheep monoclonal antibodies for use in diagnostic blood tests. This is a financially robust company which is very highly valued, but we remain sceptical about its future growth potential. We would be very interested in finding out more about this interesting company.

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Bioventix PLC

Bonkers Bargain soars on takeover - more to go for?

29/03/2021 · Company Insights

Shares in an earlier Bonkers Bargain soar on a takeover approach, but there appears to be…


Coronavirus impact: 19 Oct - boohoo tumbles (again) but others impress

19/10/2020 · Company Insights

While boohoo’s travails continue to dominate the news on AIM, several other fast-growing companies covered here…


More Company Insights

Agronomics: illustrates the crazy nature of the market

13/05/2021 · Agronomics

Bonkers Bargains: Where there’s muck…

13/05/2021